About: Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective
Creator	Cetas, Justin Fazeli, Pouneh Fleseriu, Maria Luis, · Mallea-Gil, Susana Nicholas, · Pineyro, Maria Buchfelder, · Gurnell, · Hani, · Marcus, J Mccormack, Ann Syro, V Tritos, A
Source	Medline; PMC
abstract	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain that has caused the coronavirus disease 2019 (COVID-19) pandemic, has presented healthcare systems around the world with an unprecedented challenge. In locations with significant rates of viral transmission, social distancing measures and enforced ‘lockdowns’ are the new ‘norm’ as governments try to prevent healthcare services from being overwhelmed. However, with these measures have come important challenges for the delivery of existing services for other diseases and conditions. The clinical care of patients with pituitary disorders typically involves a multidisciplinary team, working in concert to deliver timely, often complex, disease investigation and management, including pituitary surgery. COVID-19 has brought about major disruption to such services, limiting access to care and opportunities for testing (both laboratory and radiological), and dramatically reducing the ability to safely undertake transsphenoidal surgery. In the absence of clinical trials to guide management of patients with pituitary disease during the COVID-19 pandemic, herein the Professional Education Committee of the Pituitary Society proposes guidance for continued safe management and care of this population.
has issue date	2020-06-18(xsd:dateTime)
bibo:doi	10.1007/s11102-020-01059-7
bibo:pmid	32556793
has license	cc-by
sha1sum (hex)	d229138f21716710a68c8ecb056236e1a62de98e
schema:url	https://doi.org/10.1007/s11102-020-01059-7
resource representing a document's title	Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective
has PubMed Central identifier	PMC7300368
has PubMed identifier	32556793
schema:publication	Pituitary
resource representing a document's body	covid:d229138f21716710a68c8ecb056236e1a62de98e#body_text
is schema:about of	named entity 'major' named entity 'clinical' named entity 'pandemic' named entity 'services' named entity 'perspective' named entity 'Pituitary' named entity 'laboratory' named entity 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)' named entity 'presented' named entity 'typically' named entity 'Pituitary' named entity 'viral strain' named entity 'caused' named entity 'Professional' named entity 'clinical care' named entity 'pituitary' named entity 'Severe acute respiratory syndrome coronavirus 2' named entity 'multidisciplinary team' named entity 'coronavirus disease 2019' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'Pituitary' named entity 'immunosuppression' named entity 'imaging studies' named entity 'aerosolization' named entity 'serum' named entity 'primary care' named entity 'cardiovascular complications' named entity 'endocrine' named entity 'multidisciplinary approach' named entity 'thyroid disease' named entity 'Thyroid stimulating hormone' named entity 'MRI' named entity 'hyperglycemia' named entity 'prolactinoma' named entity 'hyperprolactinemia' named entity 'amenorrhea' named entity 'prolactin' named entity 'comorbidities' named entity 'lactotroph' named entity 'THRB' named entity 'COVID-19' named entity 'lanreotide' named entity 'mifepristone' named entity 'TSH' named entity 'GR antagonist' named entity 'infection' named entity 'IGF-I' named entity 'morbidity' named entity 'hyperthyroxinemia' named entity 'SARS-CoV-2' named entity 'endocrinologist' named entity 'COVID-19 pandemic' named entity 'Pituitary' named entity 'hypogonadism' named entity 'hypernatremia' named entity 'Cushing's disease' named entity 'pandemics' named entity 'pituitary adenomas' named entity 'clinical features' named entity 'diabetes mellitus' named entity 'hypopituitarism' named entity 'UFC' named entity 'IGF-1' named entity 'breast lump' named entity 'iveco' named entity 'immunosuppression' named entity 'pituitary'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software